![Bing Xian Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bing Xian Liu
Directeur Général chez Konfoong Biotech International Co., Ltd.
Postes actifs de Bing Xian Liu
Sociétés | Poste | Début | Fin |
---|---|---|---|
Konfoong Biotech International Co., Ltd.
![]() Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Directeur Général | 04/08/2011 | - |
Président | 04/08/2011 | - | |
Fondateur | 04/08/2011 | - |
Historique de carrière de Bing Xian Liu
Statistiques
Internationale
Chine | 2 |
Opérationnelle
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Konfoong Biotech International Co., Ltd.
![]() Konfoong Biotech International Co., Ltd. Medical SpecialtiesHealth Technology Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then. | Health Technology |
- Bourse
- Insiders
- Bing Xian Liu
- Expérience